CenTrial Logo

Restless Leg Syndrome Can Rob You of Sleep

by

Restless Leg Syndrome

Restless leg syndrome (RLS), also known as Willis-Ekbom disease is a type of movement disorder in which a person feels an unpleasant sensation in the legs that is eased by movement. The symptoms can spread to or even begin in arms in some cases. About 10% of the adult population is affected by this disorder.

Causes and Risk Factors of RLS

The exact cause is unknown but the following conditions are often found to be associated with pregnancy, iron deficiency anemia, Parkinson disease (a degenerative disorder of a part of the brain called basal ganglia which causes movement disorder), multiple sclerosis (an autoimmune disease in which antibody attacks neurons of the brain and spinal cord), uremia (high level of urea in the blood due to derangement in the functioning of the kidney) or nerve damage. It has a strong familial tendency. Some drugs known to exacerbate or precipitate RLS are diphenhydramine, prochlorperazine, and antidepressants.

Clinical Features of RLS

Patients often describe the sensation as a burning, creepy-crawly feeling or numbness. Some of the common terms used to describe their feelings include tingling, pulling, electric-like, tension, discomfort, and itching. The symptoms are aggravated during the night. 

About 80% of patients with RLS have periodic leg movement (PLMs) during sleep and occasionally while awake. This periodic leg movement lasts for less than a few seconds and recurs every 5-90 seconds. Restlessness during the night causes poor quality sleep and thus leads to daytime sleepiness. It can severely affect the daily life of some patients.

Diagnosing Restless Leg Syndrome

Diagnosis is made based on clinical features. Your physician will rule out other movement disorders which can mimic RLS like akathisia (feeling of inner restlessness accompanied by mental distress) and side effects of antipsychotic drugs.

Polysomnography is done to support the diagnosis, which is basically a sleep study that assesses the brain waves, heart rate, oxygenation status, and breathing of the subject while he is in a sleeping state.

The international restless legs rating scale (IRLS) is a scale to measure the degree of symptoms that a patient is experiencing. This scale also helps physicians to quantify the improvement in clinical features after starting treatment.

Tests to exclude underlying etiology include:
  • Ferritin: Ferritin is a blood test to determine the level of iron in your body. It is considered the best measure to assess the total amount of iron in the body. It is decreased in case of iron deficiency anemia.
  • Renal function test (RFT): This test determines how well your kidney is functioning. If kidney function is deranged, then urea level rises in blood  causing uremia
  • Blood glucose level
 

Managing RLS

Most patients do not require any specific treatment. Patients are often advised to adopt habits to improve sleep hygiene and quality. Some of the behavioral strategies employed include:
  • Moderate regular exercise
  • Reducing caffeine intake
  • Mental alerting activities such as doing crossword puzzles at times of boredom
  • Withdrawal of possibly predisposing medications
  • For symptomatic relief: walking, bicycling, leg massage, and soaking the affected leg
  • Avoidance of aggravating factors such as sleep deprivation

If symptoms are intractable, then dopaminergic drugs such as pramipexole, ropinirole, and rotigotine patches are prescribed by physicians. Patients are advised to take these drugs 1-2 hours before bedtime. Levodopa is also an effective drug but the drawback of this medication is that it may worsen restlessness. Since levodopa stays in the body for a short time (eliminated quickly), there is a chance of symptoms rebounding when the effect of the drug wanes.

Other effective drugs for the treatment of RLS are anticonvulsants (drugs used for the treatment of seizure), analgesics, and opiates. If RLS is found to be caused due to iron deficiency, then iron is supplemented and if it is due to kidney damage, then dialysis is advised.

Some patients also show a good response to yoga and acupuncture but enough scientific evidence is not available regarding its benefit. A Relaxis pad is a novel electronic device that applies vibratory stimulation to the legs. Some patients experience benefits with the application of this device while others may experience worsening. Therefore, it is not currently marketed and further studies about this are undergoing.

Ongoing Clinical Trials for Restless Leg Syndrome

  • Magnesium citrate supplementation: A clinical trial is currently underway to evaluate whether magnesium citrate supplementation is able to control the symptoms of RLS. Patients will be provided with 8 weeks of magnesium supplementation. The level of restlessness pre- and post-magnesium supplementation will be recorded using a standard scale called the International Restless Leg Syndrome (ILRS) scale and the Kohnen Restless Leg Syndrome Quality of Life instrument (KRL-QOL) scale.
  • Rotigotine patch: A study is underway to assess the efficacy of rotigotine patch for the treatment of restless leg syndrome. The outcome will be evaluated in terms of the degree of improvement of symptoms using the ILRS scale.
  • Trial of intravenous (iv) vs oral Iron in patients with RLS with Iron deficiency anemia (IDA): we know that oral ferrous sulfate and iv ferumoxytol are accepted treatments of IDA. In this trial, the effectiveness of these two routes of iron administration will be compared in terms of speed of resolution of symptoms. The primary outcome will be assessed at 6 weeks of treatment with a follow-up at 12-months of treatment.
  • A clinical trial is underway to evaluate the effectiveness of ferric carboxymaltose in patients with IDA and RLS. This trial is in phase II and will enroll only subjects age 18 or greater.
  • Gabapentin: Gabapentin is a widely prescribed drug for the treatment of pain originating from nerves, anxiety disorder, and bipolar disorder. A clinical trial is currently underway to assess the effectiveness of gabapentin in terms of improving symptoms of RLS.
 
References

     

Next »

Signup to be notified of clinical trials that match your condition

Clinical Trial Signup


This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition.